Scythian Biosciences Corporation

Chesapeake Gold Corp.
Latest Comments

Patent pending cannabinoid compounds bring new treatments to market

November 14, 2017
| November 14, 2017 | 4 Comments

Cannabinoids, the diverse compounds which bind to the homonymous receptors in the human body, are only recently being properly explored, […]


Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries

August 29, 2017
| August 29, 2017 | 1 Comment

Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with […]

Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids

August 14, 2017
| August 14, 2017 | 3 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]

Wealth Minerals Ltd.